{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"fetal-valproate","columns":[{"gene":"","key":"population-682d490752df3537d7a1","label":"Fetal valproate spectrum disorder","mondoId":"MONDO:0012275","onsetQualifier":null,"originColumnKey":"MONDO:0012275/ORPHA:1906","originalViews":[{"key":"MONDO:0012275/ORPHA:1906","label":"Fetal valproate spectrum disorder","scopeLabel":"ORPHA:1906","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["031bc31d9771fc141bd9c421bb40922a43d2b994573a9f27f261e318ca5c5a77","06da59612b348483b61fac63f90fbbc55d221eabbe9f911c1fca109374bdece9","49086ff0c03fc3821c80ed06824d166cc4628172624b2da12436fa50516113ef","5200f996cd3d8e6e19e45228546ef8e6aed2270511442e9b5458fe1e36552457","639d2357cdf78a2a54c66719f261ad754a2cd71fc230f9d12099f19f05d67cde","717fbbf9959063d6bbec3903f95b7da62c19df67aed144e51079004e526c2aeb","cd026ff73a86d27a5c8ee98529933389592568b1440a3ef68d736b64717d2c6f","d9361456856672b8b0a24c13bb153028da41d0ba59ea91559ef7d945f5397ccf"],"recordQualifiers":{},"scopeLabel":"ORPHA:1906","sourceIds":["ORPHA:1906"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-682d490752df3537d7a1"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000457","HP:0002714","HP:0000286","HP:0000343","HP:0000160","HP:0001539","HP:0003196"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"orphanet":8}},"features":[{"hpoId":"HP:0000457","label":"Depressed nasal ridge","primary":true},{"hpoId":"HP:0002714","label":"Downturned corners of mouth","primary":true},{"hpoId":"HP:0000286","label":"Epicanthus","primary":true},{"hpoId":"HP:0000343","label":"Long philtrum","primary":true},{"hpoId":"HP:0000160","label":"Narrow mouth","primary":true},{"hpoId":"HP:0001539","label":"Omphalocele","primary":true},{"hpoId":"HP:0003196","label":"Short nose","primary":true},{"hpoId":"HP:0000233","label":"Thin vermilion border","primary":false}],"ledeHtml":"Fetal valproate syndrome (FVS), is an anticonvulsant drug-related embryofetopathy that can occur when a fetus is exposed to valproic acid (VPA), characterized by distinct facial dysmorphism, congenital anomalies and developmental delay (especially in language and communication).","mondoId":"MONDO:0012275","node":{"canonicalSlug":"fetal-valproate","comparisons":[{"documentSha256":"208a4afa4f9869172098ffc3f54f0eaed0547b86896118814ef7fab2db6f5a04","key":"legacy-fetal-valproate","kind":"legacy","label":"fetal valproate syndrome","memberIds":["MONDO:0012275"],"mondoId":"MONDO:0012275","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/fetal-valproate.208a4afa4f9869172098ffc3f54f0eaed0547b86896118814ef7fab2db6f5a04.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"fetal valproate syndrome","paragraphs":["Fetal valproate syndrome (FVS), is an anticonvulsant drug-related embryofetopathy that can occur when a fetus is exposed to valproic acid (VPA), characterized by distinct facial dysmorphism, congenital anomalies and developmental delay (especially in language and communication)."],"scope":"exact","source":"MONDO","upstream":"Orphanet:1906","url":"https://monarchinitiative.org/MONDO:0012275"},"ownColumnKeys":["population-682d490752df3537d7a1"],"publication":"published","relationships":[{"kind":"parent","label":"syndromic disease","mondoId":"MONDO:0002254","slug":null},{"kind":"parent","label":"toxic or drug-related embryofetopathy","mondoId":"MONDO:0016677","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"031bc31d9771fc141bd9c421bb40922a43d2b994573a9f27f261e318ca5c5a77","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000160","is_excluded":false,"label":"Narrow mouth","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"06da59612b348483b61fac63f90fbbc55d221eabbe9f911c1fca109374bdece9","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001539","is_excluded":false,"label":"Omphalocele","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"49086ff0c03fc3821c80ed06824d166cc4628172624b2da12436fa50516113ef","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000286","is_excluded":false,"label":"Epicanthus","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5200f996cd3d8e6e19e45228546ef8e6aed2270511442e9b5458fe1e36552457","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000233","is_excluded":false,"label":"Thin vermilion border","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"639d2357cdf78a2a54c66719f261ad754a2cd71fc230f9d12099f19f05d67cde","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003196","is_excluded":false,"label":"Short nose","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"717fbbf9959063d6bbec3903f95b7da62c19df67aed144e51079004e526c2aeb","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000457","is_excluded":false,"label":"Depressed nasal ridge","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd026ff73a86d27a5c8ee98529933389592568b1440a3ef68d736b64717d2c6f","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000343","is_excluded":false,"label":"Long philtrum","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d9361456856672b8b0a24c13bb153028da41d0ba59ea91559ef7d945f5397ccf","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1906","disease_name":"Fetal valproate spectrum disorder","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002714","is_excluded":false,"label":"Downturned corners of mouth","onset_id":null,"reference":"ORPHA:1906","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012275\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:1906</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Fetal valproate syndrome (FVS), is an anticonvulsant drug-related embryofetopathy that can occur when a fetus is exposed to valproic acid (VPA), characterized by distinct facial dysmorphism, congenital anomalies and developmental delay (especially in language and communication).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012275\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"fetal-valproate","sourceDocuments":[{"name":"MONDO: fetal valproate syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012275"}],"sourceNote":"","synonyms":["fetal valproate syndrome","fetal valproic acid syndrome","FVS","susceptibility to valproate embryopathy","valproic acid embryopathy"],"takeawayHtml":"","title":"fetal valproate syndrome"},"schemaVersion":1}
